Tweets
Should we start considering therapeutic drug monitoring when prescribing TNFi for treatment of our rheumatologic conditions?
https://t.co/RbOlrnW54O https://t.co/iDlqwv32zs
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Zoom Fatigue is real. Study shows fatigue is from being on-cam that triggers self-presentation - the needs to monitor how you look to others; more common in women. Suggest: reduce monitor/image size & Turn off Self view (avoid self evaluation) https://t.co/KYi8bMKURy https://t.co/8fUqdpe6ia
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
BMS has announced they have filed a new drug application with the FDA and EMA for Deucravacitinib, a TYK2 inhibitor, to treat adults with moderate to severe plaque psoriasis. (w/ a PDUFA goal date of 9/10/2022) https://t.co/w5YmRYdXm4
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Improving Our Everyday RA Practice
https://t.co/eGPRMBGFjh https://t.co/y49x8MX4dK
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
The Gift of Gab: "RHEUM"
Dr. Eric Dein interviews Professor Zeide and Dr. Jason Liebowitz about a lively ACR21 talk called, "The Gift of Gab," which guided attendees on how to improve their communications.
https://t.co/fWOETKqQeP https://t.co/5b5rXzEAaQ
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Cognitive Function and Rheumatoid Arthritis: Dr. Akhil Sood Interviews Dr. Elena Myasoedova
https://t.co/k3SBwEg0WH https://t.co/1eEBUQdMAa
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
RheumNow Live will be held in person AND virtually on March 19 and 20 in Irving, TX.
Register Today!
https://t.co/ntNiWwjkFU https://t.co/NfFHgVxXa2
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Risks associated with mortality in VEXAS
https://t.co/6FIzZjlB0c https://t.co/YVoKOymWCX
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
#TBT #ACR21 Nice talk re:controversies in Behcets
Cutaneous dx: $$ favors colchicine; apremilast a nice option for refractory dx, AZA as well
Uveitis? TNF for panuveitis "1st choice" but 1/2 respond to csDMARDs as well
TCZ promising alternative; I have used w/some benefit https://t.co/XsCvhCBjS5
Mike Putman @EBRheum ( View Tweet )
4 years 7 months ago
What are the advantages and disadvantages of #ultrasound-guided intra-articular injections? Check out this slide👇from Lt.Col/Dr. Arjun's lecture:
#iracon21 #IRACON2021 @2021Iracon @APLAR_org #mskus #rheumatology https://t.co/mhq9OgBk7a
sheila @RHEUMarampa ( View Tweet )
4 years 7 months ago
JAK Safety -- The Lowdown on Infection
https://t.co/Mi6EDqP7RE https://t.co/ZVZaXHGHIk
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Rheumatology Roundup! Drs. Cush and Kavanaugh convene for their annual impromptu review of some of the best and more interesting abstracts presented at ACR 2021.
https://t.co/rp7TT6nTMA https://t.co/Zk73M6OUqO
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
